Evidence map›Paper›PMID 37873837›Full record

ArticleNeurology international2023

Acute Presentation and Long-Term Rehabilitation Follow-Up of Ischemic Myelopathy Due to Clinically Suspected Fibrocartilaginous Embolism in an Adolescent Male: A Case Report and Review.

Einat Berla, Oleg Kerzhner, Tomm Caspi, Sharon Shaklai, Dianne Michaeli

Open access · goldAbstract readCase Reports
In one paragraph

Article in Neurology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Einat BerlaIsrael Defense Forces Medical Corps, Ramat Gan 02149, Israel.ORCID 0000-0002-6313-9582
Oleg KerzhnerLoewenstein Rehabilitation Medical Center, Ra'anana 43100, Israel.ORCID 0000-0001-6752-0578
Tomm CaspiLoewenstein Rehabilitation Medical Center, Ra'anana 43100, Israel.
Sharon ShaklaiLoewenstein Rehabilitation Medical Center, Ra'anana 43100, Israel.
Dianne MichaeliLoewenstein Rehabilitation Medical Center, Ra'anana 43100, Israel.
Loewenstein Hospital Rehabilitation Center · ILTel Aviv University · ILIsrael Defense Forces Medical Corps · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic myelopathy is uncommon in the pediatric population, with fibrocartilaginous embolism (FCE) being one of its rarest causes. We present the case of an otherwise healthy 17-year-old student who experienced sudden onset of severe low-back pain amidst intensive physical training, which rapidly deteriorated to complete sensory-motor paralysis of his lower limbs. He was treated with IV Methylprednisolone and anticoagulation after the initial work-up suggested spinal cord infarction. After eight days, sufficient clinical-radiological correlation was achieved to support FCE diagnosis as the most likely cause of infarction. He subsequently received inpatient rehabilitation treatment for four months, after which he was followed as an outpatient for a total period of 16 months. While significant neurological and functional gains were achieved during this period, he also experienced some worsening. This case highlights the importance both of performing a thorough assessment and being familiar with FCE as a possible differential diagnosis of spinal cord infarction in children, to facilitate its timely identification and proper acute and long-term management. This case report was prepared following CARE guidelines after obtaining the patient's written informed consent.

Indexed as

acute myelopathycase reportfibrocartilaginous embolismischemic myelitisspinal cord infarction

Identifiers

PMID37873837
PMCPMC10594434
OpenAlexW4387774226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.